Free Trial

Protagonist Therapeutics (PTGX) Short Interest Ratio & Short Volume

$44.37
+0.03 (+0.07%)
(As of 10/4/2024 ET)

Protagonist Therapeutics Short Interest Data

Protagonist Therapeutics (PTGX) has a short interest of 3.23 million shares. This marks a -1.52% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.4, indicating that it would take 3.4 days of the average trading volume of 764,999 shares to cover all short positions.

Current Short Interest
3,230,000 shares
Previous Short Interest
3,280,000 shares
Change Vs. Previous Month
-1.52%
Dollar Volume Sold Short
$151.87 million
Short Interest Ratio
3.4 Days to Cover
Last Record Date
September 15, 2024
Outstanding Shares
58,900,000 shares
Percentage of Shares Shorted
5.48%
Today's Trading Volume
313,585 shares
Average Trading Volume
764,999 shares
Today's Volume Vs. Average
41%
Short Selling Protagonist Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Protagonist Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PTGX Short Interest Over Time

PTGX Days to Cover Over Time

PTGX Percentage of Float Shorted Over Time

Protagonist Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/20243,230,000 shares $151.87 million -1.5%N/A3.4 $47.02
8/31/20243,280,000 shares $140.68 million +5.8%N/A3.5 $42.89
8/15/20243,100,000 shares $125.83 million +6.9%N/A3.2 $40.59
7/31/20242,900,000 shares $108.58 million -11.0%N/A3.1 $37.44
7/15/20243,260,000 shares $119.81 million +59.8%N/A3.6 $36.75
6/30/20242,040,000 shares $70.69 million -34.6%N/A2.4 $34.65
6/15/20243,120,000 shares $104.18 million -7.7%N/A5.3 $33.39
5/31/20243,380,000 shares $95.15 million -2.6%N/A5.8 $28.15
5/15/20243,470,000 shares $109.20 million -7.0%N/A6.3 $31.47
4/30/20243,730,000 shares $93.66 million +6.0%N/A6.6 $25.11
4/15/20243,520,000 shares $93.56 million +2.3%N/A5.2 $26.58
3/31/20243,440,000 shares $99.52 million +0.6%N/A4.6 $28.93
3/15/20243,420,000 shares $99.11 million +16.3%N/A4.7 $28.98
2/29/20242,940,000 shares $89.32 million +5.8%N/A3.6 $30.38
2/15/20242,780,000 shares $78.48 million +6.5%N/A3.5 $28.23
1/31/20242,610,000 shares $65.28 million +2.4%N/A3.2 $25.01
1/15/20242,550,000 shares $66.05 million +8.5%N/A3.5 $25.90
12/31/20232,350,000 shares $53.89 million -41.0%N/A3.3 $22.93
12/15/20233,980,000 shares $83.86 million +9.3%N/A5.6 $21.07
11/30/20233,640,000 shares $66.28 million -0.3%N/A5.4 $18.21
11/15/20233,650,000 shares $59.46 million -7.4%N/A5.7 $16.29
10/31/20233,940,000 shares $57.29 million +15.5%N/A6 $14.54
10/15/20233,410,000 shares $52.65 million +8.3%N/A5.3 $15.44
9/30/20233,150,000 shares $52.54 million +12.5%N/A4.5 $16.68
9/15/20232,800,000 shares $50.12 million +1.8%N/A3 $17.90
8/31/20232,750,000 shares $54.51 million -9.2%N/A2.8 $19.82
8/15/20233,030,000 shares $56.84 million +2.0%N/A2.8 $18.76
7/31/20232,970,000 shares $57.62 million -10.5%N/A2.7 $19.40
7/15/20233,320,000 shares $70.55 million +4.4%N/A2.8 $21.25
6/30/20233,180,000 shares $87.83 million +18.2%N/A2.7 $27.62
6/15/20232,690,000 shares $77.15 million -12.1%N/A2.5 $28.68
5/31/20233,060,000 shares $79.77 million -15.0%N/A2.5 $26.07
5/15/20233,600,000 shares $93.49 million -3.2%N/A2.2 $25.97
4/30/20233,720,000 shares $84.07 million -14.7%N/A2.2 $22.60
4/15/20234,360,000 shares $81.71 million +0.5%N/A2.5 $18.74
3/31/20234,340,000 shares $99.82 million -16.1%N/A2.6 $23.00
3/15/20235,170,000 shares $124.34 million +88.7%N/A3.2 $24.05
2/28/20232,740,000 shares $44.44 million +5.4%6.3%1.9 $16.22
2/15/20232,600,000 shares $42.43 million +2.0%6.0%2.5 $16.32
1/31/20232,550,000 shares $33.89 million +25.6%5.9%2.7 $13.29
The Bible Says it Clear As Day (Ad)

It came to me clear-as-day thanks to the Bible… in the Parable of Talents, in the book of Matthew… This parable teaches us that it’s our duty, and our challenge, to grow our money … to invest it and put it to good use … rather than keeping it stuffed away in a savings account, or wasting it in some frivolous way. In this video, Wall Street expert Charles Mizrahi shows me a secret that has helped me … and tons of other hardworking Americans … learn to invest just like the pros on Wall

Click here to join me in the “Miracle on Main Street.”
1/15/20232,030,000 shares $24.71 million +14.0%4.7%2.4 $12.17
12/30/20221,780,000 shares $19.42 million -4.3%4.1%2.3 $10.91
12/15/20221,860,000 shares $17.73 million +6.9%4.3%2.4 $9.53
11/30/20221,740,000 shares $13.76 million -4.4%4.0%2.2 $7.91
11/15/20221,820,000 shares $14.63 million -7.6%4.2%2.4 $8.04
10/31/20221,970,000 shares $15.96 million -11.7%4.5%2.5 $8.10
10/15/20222,230,000 shares $17.82 million -8.2%5.1%2.6 $7.99
9/30/20222,430,000 shares $20.48 million -13.5%5.6%2.7 $8.43
9/15/20222,810,000 shares $23.24 million +9.3%6.5%2.8 $8.27
8/31/20222,570,000 shares $22.41 million -11.4%5.9%2.4 $8.72
8/15/20222,900,000 shares $32.86 million -31.6%6.7%2.7 $11.33
7/31/20224,240,000 shares $42.19 million -13.1%N/A3.5 $9.95
7/15/20224,880,000 shares $46.16 million +2.3%N/A3.5 $9.46
6/30/20224,770,000 shares $37.73 million +18.4%N/A3.4 $7.91
6/15/20224,030,000 shares $30.14 million +18.9%N/A3 $7.48
5/31/20223,390,000 shares $29.70 million +1.5%N/A2.9 $8.76
5/15/20223,340,000 shares $29.43 million +1.5%N/A2.9 $8.81
4/30/20223,290,000 shares $29.91 million +20.5%N/A3.1 $9.09
4/15/20222,730,000 shares $54.46 million -16.3%N/A3.3 $19.95
3/31/20223,260,000 shares $77.20 million -17.5%N/A4.6 $23.68
3/15/20223,950,000 shares $101.99 million -0.8%N/A5.7 $25.82
2/28/20223,980,000 shares $96.63 million -19.1%N/A5.6 $24.28
2/15/20224,920,000 shares $141.35 million +25.5%N/A7.3 $28.73
1/31/20223,920,000 shares $114.82 million +9.5%N/A6.4 $29.29
1/15/20223,580,000 shares $128.74 million +10.2%N/A5.9 $35.96
12/31/20213,250,000 shares $111.15 million +2.2%N/A2.4 $34.20
12/15/20213,180,000 shares $97.12 million +2.6%N/A2.2 $30.54
11/30/20213,100,000 shares $104.22 million -17.6%7.3%1.6 $33.62
11/15/20213,760,000 shares $134.38 million -15.1%8.8%1.9 $35.74
10/29/20214,430,000 shares $138.04 million +18.5%10.5%2.3 $31.16
10/15/20213,740,000 shares $115.83 million +2.8%8.9%2 $30.97
9/30/20213,640,000 shares $64.50 million +27.3%8.7%2.1 $17.72
9/15/20212,860,000 shares $132.90 million -6.5%6.8%3 $46.47
8/31/20213,060,000 shares $148.41 million -4.4%7.3%7.3 $48.50
8/13/20213,200,000 shares $152.61 million +5.6%7.6%7.3 $47.69
7/30/20213,030,000 shares $149.77 million -11.1%7.3%6.9 $49.43
7/15/20213,410,000 shares $150.93 million -1.7%8.3%8.1 $44.26
6/30/20213,470,000 shares $155.73 million -1.4%8.5%8.5 $44.88
6/15/20213,520,000 shares $134.29 million -3.8%8.6%9.3 $38.15
5/28/20213,660,000 shares $128.50 million -6.2%9.7%11.6 $35.11
5/14/20213,900,000 shares $113.10 million +26.2%N/A12.2 $29.00
4/30/20213,090,000 shares $92.67 million +1.6%N/A9.2 $29.99
4/15/20213,040,000 shares $79.01 million +0.3%N/A9.1 $25.99
3/31/20213,030,000 shares $76.69 million +5.6%N/A8.5 $25.31
3/15/20212,870,000 shares $88.97 million +3.6%N/A6.4 $31.00
2/26/20212,770,000 shares $66.45 million -0.4%N/A5.6 $23.99
2/12/20212,780,000 shares $69.75 million +1.5%N/A5.9 $25.09
1/29/20212,740,000 shares $58.25 million -13.6%N/A5.7 $21.26
1/15/20213,170,000 shares $72.43 million -7.9%N/A6.6 $22.85
12/31/20203,440,000 shares $68.77 million +28.4%N/A7.6 $19.99
The Bible Says it Clear As Day (Ad)

It came to me clear-as-day thanks to the Bible… in the Parable of Talents, in the book of Matthew… This parable teaches us that it’s our duty, and our challenge, to grow our money … to invest it and put it to good use … rather than keeping it stuffed away in a savings account, or wasting it in some frivolous way. In this video, Wall Street expert Charles Mizrahi shows me a secret that has helped me … and tons of other hardworking Americans … learn to invest just like the pros on Wall

Click here to join me in the “Miracle on Main Street.”
12/15/20202,680,000 shares $56.07 million +6.8%N/A6.6 $20.92
11/30/20202,510,000 shares $59.86 million -1.6%N/A6.9 $23.85
11/15/20202,550,000 shares $56.64 million No ChangeN/A7.2 $22.21
10/30/20202,550,000 shares $47.15 million -6.9%N/A7.2 $18.49
10/15/20202,740,000 shares $57.46 million -16.5%N/A7.9 $20.97
9/30/20203,280,000 shares $64.12 million +45.8%N/A9.5 $19.55
9/15/20202,250,000 shares $48.74 million +16.0%N/A6.3 $21.66
8/31/20201,940,000 shares $43.46 million +12.1%N/A5.4 $22.40
8/14/20201,730,000 shares $27.14 million +8.8%N/A4.2 $15.69
7/31/20201,590,000 shares $25.01 million +15.2%N/A2.8 $15.73
7/15/20201,380,000 shares $21.51 million +4.6%N/A1.3 $15.59
6/30/20201,320,000 shares $23.31 million -9.6%N/A1.2 $17.66
6/15/20201,460,000 shares $23.51 million +29.2%N/A1.4 $16.10
5/29/20201,130,000 shares $18.69 million -11.7%N/A1.2 $16.54
5/15/20201,280,000 shares $20.74 million +14.3%N/A1.4 $16.20
4/30/20201,120,000 shares $7.56 million -13.9%5.4%1.5 $6.75
4/15/20201,300,000 shares $8.87 million +4.0%6.3%8.6 $6.82
3/31/20201,250,000 shares $8.14 million -8.2%6.1%7.5 $6.51
3/13/20201,362,300 shares $9.47 million +14.5%7.0%9.5 $6.95
2/28/20201,190,000 shares $7.14 million -11.9%6.1%5.7 $6.00
2/14/20201,350,000 shares $10.30 million +3.9%6.9%2.1 $7.63
1/31/20201,300,000 shares $10.82 million +4.8%6.9%2 $8.32
1/15/20201,240,000 shares $10.39 million -20.5%6.5%1.9 $8.38
12/31/20191,560,000 shares $11.73 million +39.3%8.2%2.4 $7.52

PTGX Short Interest - Frequently Asked Questions

What is Protagonist Therapeutics' current short interest?

Short interest is the volume of Protagonist Therapeutics shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 3,230,000 shares of PTGX short. Learn More on Protagonist Therapeutics' current short interest.

What is a good short interest ratio for Protagonist Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PTGX shares currently have a short interest ratio of 3.0. Learn More on Protagonist Therapeutics's short interest ratio.

Which institutional investors are shorting Protagonist Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Protagonist Therapeutics: Susquehanna International Group LLP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Protagonist Therapeutics' short interest increasing or decreasing?

Protagonist Therapeutics saw a decrease in short interest during the month of September. As of September 15th, there was short interest totaling 3,230,000 shares, a decrease of 1.5% from the previous total of 3,280,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Protagonist Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Protagonist Therapeutics: Amphastar Pharmaceuticals, Inc. (11.43%), Calliditas Therapeutics AB (publ) (0.01%), Phibro Animal Health Co. (2.06%), Esperion Therapeutics, Inc. (19.62%), Cara Therapeutics, Inc. (2.64%), Qiagen (1.58%), Legend Biotech Co. (5.74%), Ascendis Pharma A/S (5.74%), Roivant Sciences Ltd. (9.02%), Intra-Cellular Therapies, Inc. (2.43%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($6.15 billion), Charter Communications, Inc. ($4.04 billion), Paychex, Inc. ($2.77 billion), Nu Holdings Ltd. ($2.71 billion), Cencora, Inc. ($2.34 billion), Aptiv PLC ($2.18 billion), Tractor Supply ($2.07 billion), International Paper ($2.01 billion), AppLovin Co. ($1.95 billion), and Moderna, Inc. ($1.89 billion). View all of the most shorted stocks.

What does it mean to sell short Protagonist Therapeutics stock?

Short selling PTGX is an investing strategy that aims to generate trading profit from Protagonist Therapeutics as its price is falling. PTGX shares are trading up $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Protagonist Therapeutics?

A short squeeze for Protagonist Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PTGX, which in turn drives the price of the stock up even further.

How often is Protagonist Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PTGX, twice per month. The most recent reporting period available is September, 15 2024.




This page (NASDAQ:PTGX) was last updated on 10/5/2024 by MarketBeat.com Staff
From Our Partners